Pharmaceutical Technology

JULY 30, 2024

GSK has announced a strategic collaboration with Flagship Pioneering for the discovery and development of medicines and vaccines.

Medicine 244

Medicine Vaccine Vaccination Development 244

Pharmaceutical Technology

OCTOBER 3, 2024

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.

Manufacturing 130

Manufacturing Medicine Production Trials 130

Pharmaceutical Technology

OCTOBER 4, 2024

in funding for expanding critical medicine components manufacturing. National Resilience’s subsidiary Resilience Government Services has received around $17.5m

Medicine 130

Medicine Production Manufacturing 130

Pharmaceutical Technology

MAY 18, 2023

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

Medicine 249

Medicine Pharmacy Manufacturing Production 249

Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 262

Medicine Drugs Production Research 262

Bio Pharma Dive

SEPTEMBER 27, 2023

The Swiss drugmaker is restocking its pipeline by buying into preclinical Ionis medicines for Alzheimer’s and Huntington’s diseases.

Medicine 300

Medicine RNA 300

Pharmaceutical Technology

SEPTEMBER 6, 2024

NImmune Biopharma and BioTherapeutics have partnered to develop new precision medicines in the field of inflammation and immunology.

Medicine 130

Medicine Development 130

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 17, 2024

Biology is opening up new frontiers in medicine. We are witnessing a revolution in healthcare, driven by advances in genetics, Omics, RNA and CRISPR gene-editing technology, to deliver precision and personalised medicine, said Kiran Mazumdar-Shaw, executive chairperson, Biocon and Biocon Biologics.

Genetic Disease 155

Genetic Disease Genetics Gene Editing Medicine 155

Pharmaceutical Technology

OCTOBER 26, 2023

The EC announced new initiatives to tackle critical medicine shortages in winter, introducing more flexibility to strengthen supplies.

Medicine 246

Medicine 246

Pharmaceutical Technology

MARCH 27, 2023

Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).

Medicine 246

Medicine Gene Therapy Gene Dermatology 246

pharmaphorum

OCTOBER 7, 2024

Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA

Medicine 107

Medicine 107

Pharmaceutical Technology

FEBRUARY 28, 2024

Regulatory standards concerning raw material selection are particularly stringent when it comes to Regenerative Medicines.

Medicine 243

Medicine Development 243

Pharmaceutical Technology

MAY 23, 2023

The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. The precision therapy has been designed for potently and selectively inhibiting KIT D816V, which is the main underlying driver of the disease.

FDA Approval 246

FDA Approval Medicine Trials Drugs 246

Bio Pharma Dive

JUNE 27, 2024

A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.

Medicine 345

Medicine Drugs Research 345

Pharmaceutical Technology

MAY 21, 2024

Glenmark has entered into an exclusive agreement with BeiGene to market and distribute two Beigene oncology medicines in India.

Medicine 130

Medicine Marketing 130

Pharmaceutical Technology

OCTOBER 12, 2023

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published updated guidance on valproate-containing medicines.

Containment 147

Containment Medicine Production 147

Bio Pharma Dive

OCTOBER 24, 2023

Rampart Biosciences closed a Series A round that will fund its goal to develop more potent DNA-based medicines that avoid immune responses.

DNA 272

DNA Medicine Immune Response Development 272

Pharmaceutical Technology

MAY 30, 2024

The EC has granted orphan medicinal product designation for Rocket Pharmaceuticals’ RP-A601 for PKP-2 related arrhythmogenic cardiomyopathy.

Medicine 130

Medicine Production 130

Pharmaceutical Technology

MAY 9, 2024

A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.

Medicine 130

Medicine Development Research 130

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Genetics 328

Genetics Medicine Development Gene Therapy 328

Bio Pharma Dive

SEPTEMBER 22, 2023

Results show that the medicine helped patients who progressed on earlier-line treatments live longer than those receiving chemotherapy without their disease getting worse, according to a Friday announcement.

Medicine 176

Medicine 176

Bio Pharma Dive

JULY 31, 2024

Launched last September, the company is working on a treatment for alpha-1 antitrypsin deficiency, which it said could enter the clinic in 2025.

RNA 293

RNA Medicine 293

Pharmaceutical Technology

JANUARY 31, 2024

Regeneron Pharmaceuticals has formed Regeneron Cell Medicines, a new research & development (R&D) unit in oncology and immunology.

Medicine 130

Medicine Development Research 130

Pharmaceutical Technology

JANUARY 25, 2024

We speak with BAP Pharma to learn more about the challenges and possible benefits of medicines access solutions.

Medicine 130

Medicine 130

Pharmaceutical Technology

JANUARY 9, 2024

BIOS Health has partnered with the City of Bakersfield, Kern County, and Kern Venture Group to set up a precision medicine centre in the US.

Medicine 147

Medicine 147

BioPharma Reporter

OCTOBER 8, 2024

This yearâs Nobel prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking research on microRNA.

Medicine 98

Medicine Research Development 98

Pharmaceutical Technology

JANUARY 2, 2024

PYC Therapeutics has announced plans to enter a collaboration with Google Cloud for the development of new precision medicines.

Medicine 147

Medicine Development 147

pharmaphorum

JANUARY 11, 2024

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.

Medicine 110

Medicine 110

Pharmaceutical Technology

APRIL 18, 2024

Discover the groundbreaking multi-domain active protein patented by Huadong Medicine Co Ltd for treating metabolic diseases. With increased efficacy and simplified preparation process, this protein is set to revolutionize existing treatments.

Protein 130

Protein Medicine 130

Bio Pharma Dive

OCTOBER 9, 2024

The latest deal in AI drug discovery is a twist on the usual big pharma-startup collaboration model, with Insitro licensing technology and Lilly eligible for royalties.

Medicine 167

Medicine Licensing Licensing Development 167

Pharmaceutical Technology

JANUARY 3, 2024

The UK MHRA has introduced the International Recognition procedure (IRP), a new pathway for medicine approvals.

Medicine 130

Medicine 130

Pharmaceutical Technology

JUNE 8, 2023

Biotechnology company Hopewell Therapeutics has raised $25m in seed financing to accelerate the development of next-generation lipid nanoparticles for targeted delivery of genomic medicines. Hopewell Therapeutics is engaged in discovering, synthesising and developing advanced ttLNPs to provide next-generation genomic medicines.

Genome 130

Genome Genomics Medicine Development 130

Pharmaceutical Technology

NOVEMBER 8, 2023

NICE is also working on incorporating real-world and AI-generated evidence into medicine evaluation submissions.

Medicine 147

Medicine 147

Bio Pharma Dive

MAY 25, 2022

The new initiative commits Pfizer to supplying current and future branded medicines at lower cost to 45 countries. The pharma has been criticized for not doing enough to make its COVID-19 vaccine and pill available globally.

Medicine 244

Medicine Sales Branding Vaccine 244

Pharmaceutical Technology

AUGUST 2, 2023

Revolution Medicines has signed a definitive agreement to acquire biopharmaceutical company EQRx in an all-stock transaction.

Medicine 130

Medicine 130

Pharmaceutical Technology

FEBRUARY 27, 2023

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorisation for Me rck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir).

Medicine 162

Medicine Regulation Trials Production 162

Pharmaceutical Technology

JANUARY 17, 2024

In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.

Medicine 130

Medicine Marketing 130